Diabetes study helps families sleep easier

June 20, 2014 by Paul Mayne

Two Western professors hope their clinical trial will soon lead to eliminating overnight dangers for children with Type 1 diabetes.

Schulich School of Medical & Dentistry professors Drs. Cheril Clarson and Irene Hramiak, both Lawson Health Research Institute scientists, are leading the only Canadian study evaluating a tool for preventing low blood sugars in patients while they sleep.

Low , or hypoglycemia, is a condition that can lead to coma, seizures or death for individuals with diabetes. More than half of these episodes occur during sleep hours and, in children, the rate is even higher, with 75 per cent of hypoglycemic seizures occurring overnight.

And the number of children being diagnosed each year with Type 1 diabetes – 1 in 500 – has doubled over the last few decades, Clarson said.

"If this system reduces nighttime hypoglycemia, and improves quality of life for children with diabetes and their families, it will also help patients to achieve better diabetic control and reduce the risk of long-term complications from diabetes," she added.

Currently in use, pumps help to reduce the risk of hypoglycemia by administering constant levels of insulin. However, they rely on the user to monitor their blood sugar levels and adjust as necessary – a manual task that cannot be performed while sleeping.

In the trial, Clarson and Hramiak are testing a tool that mimics the pancreas to reduce the rate of nocturnal hypoglycemia. It combines a pump to deliver insulin, a continuous glucose-monitoring system to measure blood sugars in the patient every five minutes and a computer algorithm that predicts when each individual is at risk for hypoglycemia.

Clarson said the idea is for the tool is to avoid low blood sugar by turning the insulin pump off when it predicts high risk for low-blood sugar, and then back on when the risk has been resolved.

"This study combines two technologies that have been used for quite a few years," Clarson said. "But there is no commercially available system that is fully functional, or closed loop, which is what a pancreas would be doing. This is where we're heading.

"This is a step forward because it is predicting low blood sugar, and it is much better to prevent than to have severe symptoms that often occur when the blood sugar shoots up. It's much better to prevent that from happening."

A previous trial, led by Hramiak, studied 45 adult patients age 15-45 years and yielded positive results, helping participants keep blood sugar levels stable while patients slept.

"It's a simple solution to a major problem for individuals wearing an insulin pump," Hramiak said. "We have tested the system in adults and now are testing it in a group of 20 children ages 3-15. This system could potentially prevent overnight and is a first step to developing a system that functions like a native pancreas."

Explore further: Modified iPhone shows promise against type 1 diabetes

Related Stories

Modified iPhone shows promise against type 1 diabetes

June 16, 2014
A device that uses a modified iPhone to help regulate the blood sugar of people with type 1 diabetes appears to work better than an insulin pump, researchers say.

For slumbering diabetics, a way to detect low blood sugar and stop insulin delivery

May 7, 2014
New research could soon make it easier for people with type-1 diabetes to get a safe night's sleep, says a Stanford University School of Medicine scientist who led the study.

Low blood sugar may affect heartbeat in people with diabetes

April 22, 2014
(HealthDay)—Low blood sugar levels—known as hypoglycemia—in people with diabetes may cause potentially dangerous changes in heart rate, according to a small new study.

Advances in predictive hypoglycemia-minimizing technology from Animas-JDRF collaboration

June 16, 2014
Animas Corporation today shared encouraging results from its predictive hypoglycemia-minimizing algorithm in development. Data from a clinical feasibility study demonstrated that the algorithm was capable of helping maintain ...

Bionic pancreas outperforms insulin pump in adults, youth

June 16, 2014
People with type 1 diabetes who used a bionic pancreas instead of manually monitoring glucose using fingerstick tests and delivering insulin using a pump were more likely to have blood glucose levels consistently within the ...

Diabetes Association sets new A1C target for children with type 1 diabetes

June 16, 2014
According to a new position statement released at the Association's 74th Scientific Sessions, the American Diabetes Association is lowering its target recommendation for blood glucose levels for children with type 1 diabetes, ...

Recommended for you

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

Immune system killer cells increase risk of diabetes

July 6, 2017
More than half of the German population is obese. One effect of obesity is to chronically activate the immune system, placing it under continuous stress. Researchers in Jens Brüning's team at the Max-Planck-Institute for ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.